Anlon Healthcare IPO GMP - Live Grey Market Premium

Closed
Anlon Healthcare IPO

Anlon Healthcare is a chemical manufacturing company engaged in the production of high-purity pharmaceutical intermediates and Active Pharmaceutical Ingredients (APIs). These products are used as raw materials in various finished dosages like tablets, capsules, ointments, and syrups, as well as in nutraceuticals, personal care, and veterinary products. The company is one of the few domestic manufacturers of loxoprofen sodium dihydrate, a key ingredient for pain and inflammation treatment. It has 65 commercialized products, with a robust pipeline of 28 products at the pilot stage and 49 products under lab testing. Anlon has a manufacturing facility in Rajkot, Gujarat, which is equipped with an installed capacity of 400 MTPA and four in-house laboratories. The company has received Drug Master File (DMF) approvals from regulatory bodies in Brazil, China, and Japan, which enhances its export potential.

Issue Price
91
Current GMP
2
GMP %
+2.20
Est. Listing Price
93

IPO Details

Price Range
₹86.00-91.00
Issue Size
₹121.03 Cr
Lot Size
164 shares
IPO Type
Mainboard
Open Date
26 Aug 2025
Close Date
29 Aug 2025
Allotment Date
1 Sept 2025
Listing Date
3 Sept 2025

GMP Timeline

DateIPO PriceGMPEst. Price% Change
29 Aug 2025Live
91
2
93
+2.20
28 Aug 2025
91
5
96
+5.49
27 Aug 2025
91
5
96
+5.49
26 Aug 2025
91
5
96
+5.49
25 Aug 2025
91
5
96
+5.49
24 Aug 2025
91
0
91
0.00
23 Aug 2025
91
0
91
0.00
22 Aug 2025
91
0
91
0.00
21 Aug 2025
91
0
91
0.00

Important Notes About Grey Market Premium

Grey Market Premium (GMP) is an unofficial value that indicates investor sentiment before the IPO listing. It is the premium amount at which IPO shares are traded in the grey market before they are officially listed on the stock exchange.

GMP fluctuates based on market conditions and investor sentiment. A positive GMP suggests the market expects the stock to list above its issue price, while a negative GMP suggests it may list below the issue price.

The actual listing price may differ from the estimated price based on GMP due to market conditions on the listing day. GMP is not an official indicator and should not be the sole basis for investment decisions.

IPOwiz updates the GMP values regularly, but these values are sourced from unofficial channels and should be used as a reference only.